Sarah A. Lewicki

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

UConn Health

Université Laval

Sarah A. Lewicki is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicinal chemistry, potency optimization, and structure-activity relationships.

ORCID

Publications per year

2022–2023

Publications

Stereocontrolled access to thioisosteres of nucleoside di- and triphosphates

Hai‐Jun Zhang, Michał Ociepa, Molhm Nassir et al. · Nature Chemistry · 2023 · 33 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +8

Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y 14 Receptor Antagonists

Zhiwei Wen, Asmita Pramanik, Sarah A. Lewicki et al. · Journal of Medicinal Chemistry · 2023 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y6 receptor antagonists

Kwan‐Young Jung, Qasim Shah, Sarah A. Lewicki et al. · Bioorganic & Medicinal Chemistry Letters · 2022 · 17 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Structure–Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists

Kiran S. Toti, Rajkumar Verma, Michael J. McGonnigle et al. · Journal of Medicinal Chemistry · 2022 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–4 of 4